MORF Morphic Holding, Inc.

15.31-0.18 (-1.16%)
Close: December 13, 2019

Quote

Previous Close
$15.31
Day Range
$14.72-$15.70
52 Week Range
$12.03-$33.50
Volume
42,775
Avg Volume
61,380
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$466.71M
Enterprise Value (EV)
$426.11M
PE Ratio
-
EV/EBITDA
-17.69
Price/Sales
-
Price/Book
-
PEG Ratio
-

Financials

Revenue
-
Gross Profit
-
EBITDA
-$24.09M
EPS, ttm
-
Profit Margin
-
Revenue/Employee
-
Next Earnings Date
2/26/2020 (74 days)
Debt to Equity
-266%
Debt
$145.30M
Cash
$185.90M
Net Debt
-

Performance

Beta
-0.82
200 Day Moving Avg
$18.43
50 Day Moving Avg
$15.24
52 Week Change
-14.94%
YTD Change
-16.11%
1 Month Change
-3.89%
3 Month Change
-19.63%
6 Month Change
-14.94%
1 Year Change
-14.94%
2 Year Change
-13.94%
5 Year Change
-13.94%

Share Count

Shares Outstanding
30.5M
Float
11.3M
Restricted Shares
19.2M
Restricted Shares, %
62.89%

Morphic Holding, Inc. Company Details

Sector: Health Technology

Industry: Biotechnology

CEO: Praveen P. Tipirneni

Website: -

Description: Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Employees: 37